Oncotelic Therapeutics, Inc.

Pharmaceutical company · Aguora Hills, California, United States · OTC: OTLC

Oncotelic Therapeutics, Inc. is a pharmaceutical company headquartered in Aguora Hills, California, United States. Its shares trade on OTC under the ticker OTLC. It has reported private securities offerings to the US SEC, most recently $275,000 sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Oncotelic Therapeutics at a glance

Typepharmaceutical company
HeadquartersAguora Hills, California, United States
Stock listingOTC: OTLC
SEC industryPharmaceutical Preparations
SEC CIK908259

What does Oncotelic Therapeutics do?

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $275,000 sold (2025).

Frequently asked questions about Oncotelic Therapeutics

Where is Oncotelic Therapeutics headquartered?

Oncotelic Therapeutics, Inc. is headquartered in Aguora Hills, California, United States.

What does Oncotelic Therapeutics do?

Oncotelic Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Oncotelic Therapeutics a public company?

Yes. Oncotelic Therapeutics, Inc. trades on OTC under the ticker OTLC.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences